Quviviq vs. Hydroxyzine

See how Quviviq and Hydroxyzine compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Quviviq is FDA-approved specifically for insomnia, while hydroxyzine's use for sleep is off-label, borrowed from its antihistamine side effects.

  • Quviviq is a Schedule IV controlled substance costing roughly $520 to $685 a month, while generic hydroxyzine typically runs $10 to $40 a month.

  • Both drugs can cause next-day drowsiness, so caution with driving or operating machinery the morning after applies to either one.

Quviviq vs. Hydroxyzine Drug Summary

Quviviq

Quviviq (daridorexant) is a dual orexin receptor antagonist, a class of sleep medication that blocks brain chemicals that keep you awake. It is FDA-approved for adults with insomnia and comes as a 25 mg or 50 mg tablet taken once nightly, within 30 minutes of bedtime.

Hydroxyzine

Hydroxyzine is a first-generation antihistamine FDA-approved for anxiety, itching, and pre-procedure sedation, and it's sometimes used off-label for sleep because of its sedating effects. It's taken by mouth, with typical anxiety dosing of 50 mg to 100 mg four times a day.

Quviviq vs. Hydroxyzine Side Effects

Quviviq

Most common
nasopharyngitis (up to 9.0%)
headache (up to 6.5%)
somnolence (5% to 7%)
fatigue (5% to 7%)

Hydroxyzine

Most common
drowsiness (up to 28%)
dry mouth (up to 14%)
weight gain (up to 12%)
trouble concentrating (9%)

Quviviq vs. Hydroxyzine Dosage

Quviviq

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 25 mg once nightly At the start
Maximum dose 50 mg once nightly If needed
Dose changes 1 increase As tolerated

Hydroxyzine

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 50-100 mg At the start
Maximum dose 50-100 mg Same as starting
Dose changes None Fixed dose

Quviviq vs. Hydroxyzine Indications

Quviviq

Quviviq is FDA-approved to treat insomnia in adults who have trouble falling asleep, staying asleep, or both. It works by blocking orexin receptors in the brain that keep you awake, helping you fall asleep and stay asleep through the night.

  • Difficulty falling asleep

  • Difficulty staying asleep

  • Adults only (not studied in children)

  • Not for narcolepsy (contraindicated)

Hydroxyzine

Hydroxyzine is FDA-approved for short-term anxiety relief, itching from allergic skin conditions, and pre-procedure sedation. It is not approved for insomnia, though it's often prescribed off-label at bedtime because drowsiness is one of its most common side effects.

  • Anxiety and tension (short-term)

  • Itching from allergic skin conditions

  • Pre-procedure sedation

  • Off-label: trouble sleeping (not FDA-approved)

Quviviq vs. Hydroxyzine Pros and Cons

Quviviq

Quviviq is the newest FDA-approved insomnia medication, backed by trial data on both falling asleep and staying asleep. As a Schedule IV controlled substance without a generic option, it tends to cost more and may need insurance prior authorization.

Pros

  • FDA-approved specifically for insomnia, with trial data on falling and staying asleep

  • Once-nightly dosing with no titration schedule required

  • No signs of physical dependence or withdrawal seen in clinical trials

  • No dose adjustment needed for kidney (renal) impairment

Cons

  • Schedule IV controlled substance, subject to prescription monitoring

  • Contraindicated in narcolepsy and needs caution with other CNS depressants

  • No generic version yet; costs roughly $520 to $685 a month without insurance

  • Newer drug (approved 2022) with less long-term real-world data than older options

Hydroxyzine

Hydroxyzine is a decades-old antihistamine doctors sometimes prescribe off-label for sleep because drowsiness is one of its main side effects. It's inexpensive and widely available, but it lacks insomnia-specific trial data and carries more anticholinergic baggage.

Pros

  • Inexpensive generic, typically $10 to $40 a month without insurance

  • Decades of clinical use across anxiety, allergy, and sedation settings

  • Not a controlled substance, so no misuse classification or extra monitoring

  • Also treats itching and pre-procedure anxiety, useful for overlapping symptoms

Cons

  • Not FDA-approved for insomnia; sleep use is off-label

  • Anticholinergic effects like dry mouth and constipation, more pronounced in older adults

  • Carries a QT-prolongation warning on its label

  • Efficacy specifically for sleep hasn't been studied the way Quviviq's has

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.